cdmo.directory
← Compare landing

Hillgene vs Porton Advanced

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryHillgenePorton Advanced
SummaryHillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe.
Services
  • Regulatory Affairs
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Cell-Line Development
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Development capabilities
  • Analytical method development
  • Formulation development
  • Cell line development
  • Analytical method development
  • Formulation development
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Cell-Free
  • Single-Use / Disposable
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Cell-Free
Locations
  • Headquarters, Suzhou, Jiangsu, China
  • R&D Center, Suzhou, Jiangsu, China
  • GMP Facility, Belgium, Belgium
  • Ascendas Park Campus, Suzhou, Jiangsu, China
  • Sangtiandao Campus, Suzhou, Jiangsu, China
  • Cranbury Campus, Cranbury, New Jersey, United States
  • Chongqing Beibei R&D Site, Chongqing, Chongqing, China
  • Chongqing Changshou Manufacturing Site, Chongqing, Chongqing, China
  • Chongqing Beibei Manufacturing Site, Chongqing, Chongqing, China
  • Shanghai Minhang R&D Site, Shanghai, Shanghai, China
  • Shanghai Fengxian Manufacturing Site, Shanghai, Shanghai, China
  • Shanghai Pudong R&D and Manufacturing Site, Shanghai, Shanghai, China
  • Jiangxi Yichun Manufacturing Site, Yichun, Jiangxi, China
  • Hubei Xiaogan Manufacturing Site, Xiaogan, Hubei, China
  • J-STAR South Plainfield R&D Site, South Plainfield, New Jersey, United States
  • J-STAR Cranbury R&D Site, Cranbury, New Jersey, United States
  • Porton Advanced Shipping/Logistic Center, Cranbury, New Jersey, United States
  • Copenhagen Office, Copenhagen, Copenhagen, Denmark
  • Turnhout Office, Turnhout, Turnhout, Belgium
  • Slovenia R&D and Manufacturing Site, Ljubljana, Ljubljana, Slovenia
  • Root Office, Root, Root, Switzerland
Certifications
  • FDA · Identifier: DMF filing approval for genetically modified K562 feeder cells
Data not yet provided.

Find similar companies

Hillgene alternatives · Porton Advanced alternatives

Markdown mirror: /compare/hillgene/porton-advanced.md